Leptin Reduces the Expression and Increases the Phosphorylation of the Negative Regulators of GLUT4 Traffic TBC1D1 and TBC1D4 in Muscle of ob/ob Mice by Sáinz, Neira et al.
Leptin Reduces the Expression and Increases the
Phosphorylation of the Negative Regulators of GLUT4
Traffic TBC1D1 and TBC1D4 in Muscle of ob/ob Mice
Neira Sa ´inz
1,4, Amaia Rodrı ´guez
1,4, Victoria Catala ´n
1,4, Sara Becerril
1,4, Beatriz Ramı ´rez
1,4, Andoni
Lancha
1,4, Emma Burgos-Ramos
3,4, Javier Go ´mez-Ambrosi
1,4, Gema Fru ¨hbeck
1,2,4*
1Metabolic Research Laboratory, Universidad de Navarra, Pamplona, Spain, 2Department of Endocrinology and Nutrition, Clı ´nica Universidad de Navarra, Pamplona,
Spain, 3Department of Endocrinology, Hospital Infantil Universitario Nin ˜o Jesu ´s, Madrid, Spain, 4CIBER Fisiopatologı ´a de la Obesidad y Nutricio ´n (CIBERobn), Instituto de
Salud Carlos III, Pamplona, Spain
Abstract
Leptin improves insulin sensitivity in skeletal muscle. Our goal was to determine whether proteins controlling GLUT4 traffic
are altered by leptin deficiency and in vivo leptin administration in skeletal muscle of wild type and ob/ob mice. Leptin-
deficient ob/ob mice were divided in three groups: control, leptin-treated (1 mg/kg/d) and leptin pair-fed ob/ob mice.
Microarray analysis revealed that 1,546 and 1,127 genes were regulated by leptin deficiency and leptin treatment,
respectively. Among these, we identified 24 genes involved in intracellular vesicle-mediated transport in ob/ob mice. TBC1
domain family, member 1 (Tbc1d1), a negative regulator of GLUT4 translocation, was up-regulated (P=0.001) in ob/ob mice
as compared to wild types. Importantly, leptin treatment reduced the transcript levels of Tbc1d1 (P,0.001) and Tbc1d4
(P=0.004) in the leptin-treated ob/ob as compared to pair-fed ob/ob animals. In addition, phosphorylation levels of TBC1D1
and TBC1D4 were enhanced in leptin-treated ob/ob as compared to control ob/ob (P=0.015 and P=0.023, respectively) and
pair-fed ob/ob (P=0.036 and P=0.034, respectively) mice. Despite similar GLUT4 protein expression in wild type and ob/ob
groups a different immunolocalization of this protein was evidenced in muscle sections. Leptin treatment increased GLUT4
immunoreactivity in gastrocnemius and extensor digitorum longus sections of leptin-treated ob/ob mice. Moreover, GLUT4
protein detected in immunoprecipitates from TBC1D4 was reduced by leptin replacement compared to control ob/ob
(P=0.013) and pair-fed ob/ob (P=0.037) mice. Our findings suggest that leptin enhances the intracellular GLUT4 transport in
skeletal muscle of ob/ob animals by reducing the expression and activity of the negative regulators of GLUT4 traffic TBC1D1
and TBC1D4.
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Introduction
Skeletal muscle constitutes the tissue with the highest insulin-
stimulated glucose uptake. Of several potential facilitative glucose
transporters (GLUTs) the GLUT4 isoform is primarily expressed
in insulin-responsive tissues, including skeletal muscle and adipose
tissue. Insulin stimulates the traffic of GLUT4-containing vesicles
to the cell surface and induces their fusion to the plasma
membrane [1]. GLUT4 is a continuosly recycling membrane
protein with defects in the translocation of GLUT4 from
intracellular depots to the plasma membrane being associated
with insulin resistance in muscle cells and adipocytes [2].
A key signal transduction pathway for GLUT4 translocation is
the Akt-induced phosphorylation of Rab GTPase-activating
protein (GAP) AS160, also known as TBC1 domain family,
member 4 (TBC1D4) [3]. The phosphorylation of TBC1D4
suppresses its GAP activity, thereby triggering the machinery for
the docking of GLUT4 vesicles to the plasma membrane [4].
More recently, several groups have characterized a paralog of
TBC1D4 important for regulating body weight and linked to
obesity, known as TBC1D1, that is predominantly expressed in
skeletal muscle [5,6]. Both TBC1D4 and TBC1D1 have been
defined as negative regulators of GLUT4 vesicle translocation to
the plasma membrane [7]. On the other hand, the fusion of
GLUT4-containing vesicles with the plasma membrane in muscle
and fat cells is mediated by SNAP-associated receptor (SNARE)
proteins, such as synaptosomal-associated protein 23 (SNAP23),
syntaxin 4, and vesicle-associated membrane protein 2 (VAMP2).
This process can be negatively regulated by Munc18c (mammalian
homologue of Unc-18) and syntaxin 4-binding protein (Stxbp4,
also known as Synip) [8,9].
Leptin, the product of the ob gene, is an adipose-derived
hormone that acts as an afferent signal in a negative-feedback loop
inhibiting the appetite and regulating adiposity [10,11]. In
addition to its central function as a satiety factor, many peripheral
effects of leptin on metabolism have been described [12,13].
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models [14,15]. The hormone increases the basal and insulin-
induced glucose uptake in isolated muscles of rodents as well as in
cultured cells in a PI3-kinase (PI3K)-dependent manner [16,17].
Furthermore, activation of AMP-activated protein kinase (AMPK)
stimulates the gene expression of GLUT4 [18] and promotes its
translocation to the sarcolemma [19] with leptin activating AMPK
in skeletal muscle [20,21].
In this study, we show for the first time, the in vivo participation
of leptin in the regulation of gene expression and phosphorylation
of TBC1D1 and TBC1D4, key molecules in the traffic of GLUT4
in skeletal muscle of leptin-deficient ob/ob mice.
Methods
Animals and Treatments
Ten-week-old male obese ob/ob mice (Lep
ob/Lep
ob, C57BL/
6J) (n=18) and their lean wild type littermate controls (n=6)
(Harlan, Barcelona, Spain), were housed in a room with
controlled temperature (2262uC) and a 12:12 light-dark cycle.
The ob/ob mice were divided in control, leptin-treated and pair-
fed groups (n=6 per group). The wild type as well as the control
ob/ob and pair-fed ob/ob groups received vehicle (PBS), while
leptin-treated ob/ob mice were intraperitoneally administered
with leptin (1 mg/kg/d) (Bachem, Bubendorf, Switzerland) twice
daily at 08:00 am and 08:00 pm for 28 days. Wild type, control
ob/ob and leptin-treated ob/ob groups were provided with water
and food ad libitum with a standard rodent chow (2014S Teklad,
Harlan), while daily food intake of the pair-fed ob/ob group was
matched to the amount eaten by the leptin-treated ob/ob group
the day before to discriminate the inhibitory effect of leptin on
appetite. Mice were sacrificed on the 28th day of treatment by
CO2 inhalation 20 h after the last PBS or leptin administration
(in order to avoid picking up effects reflecting an acute response)
and after 8 h of fasting. Fasting blood and the gastrocnemius,
extensor digitorum longus (EDL) and soleus muscles in fasted-
basal conditions were obtained for biochemical and molecular
analyses. The gastrocnemius muscle from one hindleg was
removed for mRNA and protein extraction. Triacylglycerol (TG)
content in gastrocnemius muscle was measured using a
commercially available method (Wako, Osaka, Japan). The
contralateral hindleg gastrocnemius, as well as the EDL and the
soleus muscles were formalin-fixed for immunohistochemical
analyses All experimental procedures conformed to the European
Guidelines for the Care and Use of Laboratory Animals
(directive 86/609). The protocol was approved by the Ethical
Committee for Animal Experimentation of the University of
Navarra (080/05).
Blood Analyses
Serum glucose was analyzed using a sensitive-automatic
glucose sensor (Ascensia Elite, Bayer, Barcelona, Spain). Serum
TG concentrations were spectrophotometrically determined
using a commercial kit (Infinity, Thermo Electron, Melbourne,
Australia). Free fatty acids (FFA) concentrations were measured
using the colorimetric NEFA C kit (Wako), while glycerol was
evaluated by enzymatic methods [22]. ELISA kits were used to
assess insulin, leptin (Crystal Chem Inc., Chicago, IL, USA) and
adiponectin (BioVendor Laboratory Medicine, Inc., Modrice,
Czech Republic) concentrations. Insulin resistance was estimated
using the HOMA index (fasting insulin [mU/mL]6fasting glucose
[mmol/L]/22.5). Insulin sensitivity was determined using the
QUICKI index (1/[log(fasting insulin mU/mL)+log(fasting glu-
cose mg/dL)].
Microarray
Total RNA was extracted from gastrocnemius muscle samples
(20–30 mg) of wild type, control ob/ob and leptin-treated ob/ob
mice using TRIzol
TM reagent (Invitrogen, Barcelona, Spain) as
previously described [21]. Gene expression analyses were
conducted using the Agilent Whole Mouse Genome array
(G4121B, Agilent Technologies, Santa Clara, CA, USA), contain-
ing more than 41,000 mouse transcripts. Briefly, 1 mg of total
RNA from each sample was amino-allyl labelled and amplified
using the Amino Allyl MessageAmp II aRNA Amplification Kit
(Ambion, Austin, TX, USA). Amplified aRNA was fluorescently
labelled using Cy3/Cy5 (Amersham Biosciences, Buckingham-
shire, UK) and hybridized to Agilent oligomicroarrays. Two
hybridizations with fluor reversal (Dye swap) were performed for
each sample (n=5 per group). Microarray slides were scanned
(Gene Pix 4100A scanner, Axon Instruments, Union City, CA,
USA) and the images quantified with the software GenePiX Pro
6.0. Gene expression data were analyzed using the GeneSpring
GX software v. 7.3.1 (Agilent Technologies). Clustering was
accomplished with the Gene and Condition Tree algorithms.
Gene Ontology groupings (http://babelomics.bioinfo.cipf.es) and
the KEGG website (http://www.genome.ad.jp/kegg/pathway)
were used in conjunction with GeneSpring (http://www.agilent.
com/chem/genespring) to identify pathways and functional
groups of genes modified by leptin deficiency and administration.
All microarray data reported are described in accordance with
MIAME guidelines. More information regarding the microarray
experiments can be found at the EMBL-European Bioinformatics
Institute (http://www.ebi.ac.uk/aerep/login. ArrayExpress acces-
sion number: E-MEXP-1831).
Real-Time PCR
For first strand cDNA synthesis, constant amounts of total RNA
isolated from the gastrocnemius muscle of wild type, control ob/ob,
pair-fed ob/ob and leptin-treated ob/ob were reverse-transcribed as
previously described [21]. Specific primers and probes to each
target gene were designed using the software Primer Express 2.0
(Applied Biosystems, Foster City, CA, USA) (Table 1). The cDNA
was amplified using the TaqManH Universal PCR Master Mix
(Applied Biosystems) and the transcript levels for Tbc1d1, Tbc1d4
and Slc2a4 (Glut4) were quantified by Real-Time PCR (7300 Real-
Time PCR System, Applied Biosystems). All results were
normalized to the levels of 18S rRNA (Applied Biosystems) and
relative quantification was calculated using the DDCt formula.
Preparation of Tissue Lysates
Gastrocnemius, EDL and soleus muscles (10–70 mg) were
homogenized in ice-cold lysis buffer (10 mmol/L EDTA?2H2O,
50 mmol/L NaCl; 1% Triton X-100, 2 mmol/L phenylmethyl-
sulfonyl fluoride) supplemented with a protease inhibitor cocktail
(Complete
TM Mini-EDTA free, Roche Molecular Biochemicals,
Mannheim, Germany) and phosphate inhibitors (50 mmol/L
sodium pyrophosphate, 0.1 mol/L NaF, 10 mmol/L Na3VO4).
Lysates were centrifuged (16,000 g,4 uC) for 25 min and protein
concentrations determined in the supernatants (Bio-Rad Labora-
tories, Inc., Hercules, CA, USA).
Immunoprecipitation
TBC1D1 and TBC1D4 proteins were immunoprecipitated
from gastrocnemius lysates (250 mg of total protein) using rabbit
polyclonal anti-TBC1D1 and TBC1D4 antibodies (Cell Signaling,
Inc., Danvers, MA, USA) overnight at 4uC, followed by
incubation with protein A-agarose beads (Roche) for 2 h at 4uC.
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supernatants were removed. Bead-antibody-protein complexes
were washed in lysis buffer and proteins were eluted from protein
A-agarose beads by boiling in Laemmli buffer.
Immunoblots
Muscle lysates (30 mg) and immunoprecipitates were run out in
10% SDS-PAGE, subsequently transferred to nitrocellulose
membranes (Bio-Rad Laboratories) and blocked in Tris-buffered
saline (10 mmol/L Tris-HCl, 150 mmol/L NaCl, pH 8.00) with
0,05% Tween 20 (TBS-T) containing 5% BSA (Sigma, St. Louis,
MO, USA) for 2 h at room temperature (RT). Blocked
membranes of lysates and immunoprecipitates were probed with
the primary antibodies rabbit polyclonal anti-GLUT4 (Abcam,
Cambridge, UK) and rabbit polyclonal anti-phospho-Akt-sub-
strate (PAS) (Cell Signaling), in blocking buffer overnight at 4uC.
The antigen-antibody complexes were visualized using horseradish
peroxidase (HRP)-conjugated anti-rabbit, anti-mouse (Amersham
Biosciences) (Abcam) IgG antibodies in TBS-T containing 5%
non-fat dry milk for 1 h at RT and the enhanced chemilumines-
cence ECL Plus detection system (Amersham Biosciences).
Membranes of immunoprecipitates probed with PAS and GLUT4
antibodies were stripped and re-probed with the corresponding
total antibody rabbit polyclonal anti-TBC1D1 and anti-TBC1D4
(Cell Signaling). The signals from PAS-TBC1D1, PAS-TBC1D4,
GLUT4-TBC1D1 and GLUT4-TBC1D4 were related to total
TBC1D1 and TBC1D4 in the immunoprecipitate sample. Mouse
monoclonal anti-b-actin (Sigma) was used for normalization of
GLUT4 density values from total protein lysates of muscle. Bands
were analyzed by densitometric analysis using the Gel Doc-
Quantity One 4.5.0., Bio-Rad).
Immunohistochemistry
Sections (5 mm) of formalin-fixed paraffin-embedded muscles
(gastrocnemius, EDL and soleus) were dewaxed in xylene and
rehydrated in decreasing concentrations of ethanol. Slides were
blocked with 5% normal goat serum (Sigma) diluted in TBS
(0.05 mol/L Tris-HCl buffer, 0.5 mol/L NaCl, pH 7.36) for
30 min at RT followed by incubation with the rabbit polyclonal
anti-GLUT4 antibody (Abcam) in TBS with 5% normal goat
serum overnight at 4uC. After washing, the endogen peroxidase
activity was quenched using 3% H2O2 (Sigma) in distilled water
for 20 min at RT. Sections were incubated with goat anti-rabbit
EnVision-HRP conjugate (Dako Corporation, Hamburg, Ger-
many) for 20 min at RT after subsequent washing. The
immunocomplexes were visualized by adding 0.03% 3,3-diami-
nobenzidine (Dako) as developing system. Negative control slides
with omission of the primary antibodies were included. The
reaction was stopped and contrasted with Harris’ hematoxylin
solution (Sigma). Sections were dehydrated and mounted in
DePeX (Panreac, Barcelona, Spain).
Statistical Analyses
All statistical analyses were performed using SPSS 15.0 (SPSS,
Chicago, IL, USA). Differences between groups were assessed by
one-way ANOVA followed by LSD tests. As previously outlined,
Gene Ontology groupings were used to identify pathways
significantly affected by leptin deficiency and administration.
Statistical comparisons for microarray data to identify differen-
tially expressed genes across different groups were performed using
one-way ANOVA and Student’s t-tests as appropriate. Data are
expressed as mean6SEM. Statistical significance was defined as
P,0.05.
Results
Metabolic profile of wild type and ob/ob mice
As expected, leptin treatment corrected the obese and diabetic
phenotype of ob/ob mice (Table 2). Body weight of leptin-treated
ob/ob animals was reduced by leptin treatment as compared to the
control ob/ob (P,0.0001) and pair-fed ob/ob (P,0.0001) groups.
Leptin administration normalized both glucose (P=0.961) and
insulin (P=0.985) concentrations in leptin-treated ob/ob mice
compared to wild types. Moreover, leptin increased insulin
sensitivity in peripheral tissues, as evidenced by the higher
QUICKI index in the leptin-treated ob/ob mice than in the
control ob/ob (P,0.0001) and pair-fed ob/ob (P=0.007) groups,
with no statistical differences between wild type and leptin-treated
ob/ob animals.
Leptin alters gene expression of key regulators of GLUT4
traffic
Differential gene expression profiles in the gastrocnemius
muscle of wild type, control ob/ob and leptin-treated ob/ob groups
were compared by microarray analysis. Leptin repressed 736
genes that were up-regulated in the control ob/ob and increased
the transcript levels of 846 down-regulated genes. As shown in
Table 3, functional analysis of the genes revealed that a number of
these are involved in the insulin signaling pathway and glucose
metabolism processes.
To further characterize the actions of leptin on intracellular
GLUT4 traffic, we then decided to focus on the set of genes
Table 1. Sequences of the primers and TaqmanH probes used in the Real-Time PCR analysis.
Gene Name Gene Symbol GenBank accesion number Oligonucleotide sequence (59-39)
Solute carrier family 2 (facilitated glucose Glut4 NM_009204 Forward: GTCCTGAGAGCCCCAGATACCT
transporter), member 4 (Slc2a4) Reverse: TCCAACTTCCGTTTCTCATCCTT
Probe: FAM-CCTGCCCGAAAGAGTCTAAAGCGCC-TAMRA
TBC1 domain family, member 1 Tbc1d1 NM_019636 Forward: GTCCTGACACCAAAAAGATTGCA
Reverse: TCTCGGCAGATGAATCCAAAGT
Probe: FAM-TTGCTCTCAGGGCATCAGACATGTGG-TAMRA
TBC1 domain family, member 4 Tbc1d4 NM_001081278 Forward: CACTAAATCAGTCGTGCTGGAGAA
Reverse: CGACAGATAAAGCCAAAGTGATCA
Probe: FAM-CCTCTTGTTCTCAGGGAATAAAGCAT-TAMRA
doi:10.1371/journal.pone.0029389.t001
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Wild type Control ob/ob Pair-fed ob/ob Leptin-treated ob/ob
Body weight (g) 25.860.6 51.061.2
d 34.161.3
g 24.460.8
g,k
Glucose (mg/dL) 184634 425627
d 187617
g 182625
g
TG (mg/dL) 111610 154611
b 135687 9 610
a,g,j
FFA (mmol/L) 1.2760.17 1.3360.17 2.2860.63
e 0.7760.07
i
Glycerol (mmol/L) 48686 0 665 4 610 1163
d,g,j
Insulin (ng/mL) 0.4560.08 10.0361.32
d 2.6560.63
g 0.4760.08
g,h
Adiponectin (mg/mL) 33.262.0 21.661.0
c 35.362.0
g 40.962.3
b,g,h
HOMA 5.561.5 252.8634.5
d 31.568.6
g 5.561.4
g
QUICKI 0.31860.021 0.20160.002
d 0.25560.013
f 0.31160.013
g,i
TG (mg/g) 1.1560.09 1.9360.14
a 1.2060.10
g 1.2060.17
g
Data are mean 6 SEM (n=6 per group). Differences between groups were analyzed by one-way ANOVA followed by LSD test.
aP,0.05,
bP,0.01,
cP,0.001 and
dP,0.0001 vs wild type.
eP,0.05,
fP,0.01 and
gP,0.001 vs control ob/ob.
hP,0.05,
iP,0.01,
jP,0.001 and
kP,0.0001 vs pair-fed ob/ob. TG: triacylglycerol; FFA: free fatty acids; HOMA: homeostasis model assessment; QUICKI: quantitative insulin sensitivity check index.
doi:10.1371/journal.pone.0029389.t002
Table 3. Biological processes according to Gene Ontology (GO) altered by leptin deficiency and leptin administration in the
gastrocnemius muscle.
Category wild type vs ob/ob ob/ob vs leptin
P value P value
GO:15031: Protein transport 0.971 0.002
GO:46907: Intracellular transport 0.997 0.062
GO:6886: Intracellular protein transport 0.919 0.033
GO:16192: Vesicle-mediated transport 0.985 0.344
GO:5975: Carbohydrate metabolism 0.001 0.129
GO:7264: Small GTPase mediated signal transduction 0.815 0.247
GO:44262: Cellular carbohydrate metabolism 0.005 0.064
GO:30705: Cytoskeleton-dependent intracellular transport 0.999 0.164
GO:6092: Main pathways of carbohydrate metabolism 0.010 0.089
GO:6006: Glucose metabolism 0.040 0.062
GO:51056: Regulation of small GTPase mediated signal transduction 0.944 0.980
GO:48193: Golgi vesicle transport 0.985 0.263
GO:44275: Cellular carbohydrate catabolism 0.169 0.097
GO:16052: Carbohydrate catabolism 0.169 0.097
GO:6007: Glucose catabolism 0.078 0.081
GO:6096: Glycolysis 0.047 0.232
GO:51050: Positive regulation of transport 0.873 0.041
GO:45807: Positive regulation of endocytosis 0.778 0.113
GO:8286: Insulin receptor signaling pathway 0.173 0.033
GO:42593: Glucose homeostasis 0.317 0.424
GO:1678: Cell glucose homeostasis 0.070 0.104
P values (FDR adjusted P values) reflect the significance of change in prevalence of genes in each category under the leptin deficiency (ob/ob) and leptin administration
(leptin) conditions in ob/ob mice to the expected prevalence of genes in each category. Statistical significant P values are highlighted in bold.
doi:10.1371/journal.pone.0029389.t003
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process. Table 4 shows that 24 genes encoding proteins involved
in the vesicle-mediated transport between the plasma membrane
and the intracellular reservoirs were modified by leptin in ob/ob
mice. Among them, leptin increased gene expression of the glucose
transporters Slc2a3 (Glut3) and Slc2a12 (Glut12), while it decreased
the mRNA levels of the inhibitors of GLUT4 translocation Tbc1d1
and Tbc1d4, as compared to control ob/ob mice. On the contrary,
the expression of the genes involved in the fusion to the membrane
of GLUT4-containing vesicles, Vamp2, Vamp4, Vamp5 and Vamp8,
Stxbp4, Stx8 and Sybl1, was up-regulated by leptin administration in
ob/ob animals.
Expression of GLUT4 in skeletal muscle of wild type and
ob/ob mice
No differences for GLUT4 mRNA levels GLUT4 in homog-
enates of gatrocnemius and soleus muscles between wild type and
ob/ob groups were found. However, gene expression levels of
GLUT4 were reduced in EDL of control ob/ob (P=0.007) as
compared with wild types, while no effect of leptin administration
was detected (Figure 1A). Protein abundance of GLUT4 was not
affected by leptin deficiency and leptin administration in
gastrocnemius, EDL and soleus muscles of ob/ob mice
(Figure 1B). To characterize the involvement of leptin on GLUT4
translocation to the plasma membrane an immunohistochemical
analysis for the GLUT4 protein in muscle sections of the diverse
groups was performed. As shown in Figure 2, a different pattern of
GLUT4 immunostaining was detected between muscle sections of
wild type and ob/ob groups. In wild types, GLUT4 staining was
almost exclusively relegated to some gastrocnemius fibers, with
typical intracellularly scattered punctate and non-continuous
staining observed in the cell surface. In contrast, in leptin-deficient
mice (control ob/ob and pair-fed ob/ob groups) the staining pattern
of GLUT4 was uniformly distributed among almost all the
gastrocnemius fibers. Interestingly, leptin increased immunoreac-
tivity of GLUT4 in some gastrocnemius fiber sections of the leptin-
treated ob/ob group as compared to control ob/ob and pair-fed ob/
ob mice, consistent with the GLUT4 staining pattern of wild types.
In EDL sections, GLUT4 immunostaining was not altered by
leptin deficiency but leptin treatment markedly enhanced
immunoreactivity for GLUT4 in muscle sections of leptin-treated
ob/ob mice. In contrast, a lower immunostaining for GLUT4 was
observed in the soleus sections of control ob/ob as compared to
wild types and no effect of leptin replacement was detected.
Table 4. Genes involved in vesicle-mediated transport altered by leptin in the gastrocnemius muscle of ob/ob mice.
GenBank Number Gene Symbol Gene Name Fold change Ratio
ob/ob leptin
Genes down-regulated by leptin
NM_019636 Tbc1d1 TBC1 domain family, member 1 1.84 0.80 0.44
AK220347 Tbc1d4 TBC1 domain family, member 4 1.19 0.64 0.54
NM_016810 Gosr1 Golgi SNAP receptor complex member 1 0.94 0.59 0.63
NM_019661 Ykt6 YKT6 v-SNARE protein 0.95 0.64 0.67
NM_133704 Sec22l2 SEC22 vesicle trafficking protein homolog A 1.42 1.05 0.74
NM_019829 Stx5a Syntaxin 5 0.79 0.59 0.75
NM_019650 Gosr2 Golgi SNAP receptor complex member 2 1.09 0.84 0.77
NM_133854 Snapap SNAP-associated protein 0.99 0.81 0.82
NM_172675 Stx16 Syntaxin 16 0.86 0.74 0.86
Genes up-regulated by leptin
NM_019972 Sort1 Sortilin 1 0.69 1.18 1.71
NM_178934 Slc2a12 Solute carrier family 2 (facilitated glucose transporter), member 12 0.67 1.09 1.63
NM_011505 Stxbp4 Syntaxin binding protein 4 1.41 2.24 1.59
NM_016794 Vamp8 Vesicle-associated membrane protein 8 1.14 1.65 1.45
AF093064 Stx8 Syntaxin-like protein 3I35 1.06 1.53 1.44
AK049750 Sec22l3 SEC22 vesicle trafficking protein-like 3 1.00 1.41 1.41
AK018344 Vamp4 Vesicle-associated membrane protein 4 0.69 0.89 1.29
NM_011401 Slc2a3 Solute carrier family 2 (facilitated glucose transporter), member 3 0.99 1.26 1.27
NM_011515 Sybl1 Synaptobrevin like 1 1.02 1.27 1.25
NM_016872 Vamp5 Vesicle-associated membrane protein 5 0.98 1.21 1.23
NM_009222 Snap23 Synaptosomal-associated protein 23 0.95 1.16 1.22
NM_023348 Snap29 GS32 protein 0.77 0.94 1.22
NM_009497 Vamp2 Vesicle-associated membrane protein 2 1.15 1.34 1.17
NM_009294 Stx4a Syntaxin 4
a 0.89 1.03 1.16
NM_011342 Sec22l1 SEC22 vesicle trafficking protein-like 1 1.02 1.12 1.10
Differential expression of genes is indicated as fold changes with respect to the wild type group presenting only the genes which were significantly different (P,0.05)
between the leptin-treated and the control ob/ob groups. Ratio: fold change value for leptin-treated vs the ob/ob group.
doi:10.1371/journal.pone.0029389.t004
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Tbc1d4 in skeletal muscle of ob/ob mice
Consistently with microarray data, real-time PCR analyses
demonstrated that Tbc1d1 mRNA levels were up-regulated in
gastrocnemius of control ob/ob mice as compared to wild types
(P=0.0012). A trend towards higher transcript levels of Tbc1d4
between control ob/ob and wild type groups was detected.
However, no significant differences were observed (P=0.066).
Importantly, leptin replacement reduced the expression of Tbc1d1
(P=0.0005) and Tbc1d4 (P=0.004) in gastrocnemius of leptin-
treated ob/ob as compared to control ob/ob animals (Figure 3A–B).
In addition, higher (P=0.05) transcript levels of Tbc1d1 were
detected in EDL of control ob/ob as compared to wild types. No
effect of either leptin deficiency or leptin administration was
detected for mRNA levels of Tbc1d1 and Tbc1d4 in the soleus
muscle (Figure 3A–B).
Leptin increases the phosphorylation of TBC1D1 and
TBC1D4 in ob/ob mice
The phosphorylation status of TBC1D1 and TBC1D4 in the
gastrocnemius of wild type and ob/ob mice was determined using
the PAS antibody. Figure 4A evidences multiple PAS bands in all
the groups and reveals a general increase of the PAS signal in the
leptin-treated ob/ob group. Among the PAS bands detected in the
anti-PAS immunoblot, a band migrating at approximately the
150-kDa location was included. Moreover, this band was reduced
in control ob/ob as compared to wild type mice and increased after
leptin treatment. This band migrated at a location that may
correspond to the molecular weight of the TBC1D1 and TBC1D4
proteins. However, the PAS antibody does not distinguish between
TBC1D1 and TBC1D4 phosphorylation. Thus, the relative
contribution of these two proteins to the PAS signal can not be
discerned using this antibody. To resolve this question, protein
homogenates of gastrocnemius were immunoprecipitated using
TBC1D1 and TBC1D4 antibodies. PAS levels in immunoprecip-
itate samples of TBC1D1 (Figure 4B and C, P=0.048) and
TBC1D4 (Figure 4B and D, P=0.025) were lower in gastrocne-
mius of control ob/ob as compared to wild type animals. No
statistically significant differences were observed for PAS-TBC1D1
and PAS-TBC1D4 protein levels between the control ob/ob and
pair-fed ob/ob groups. Importantly, signals from PAS-TBC1D1
and PAS-TBC1D4 were substantially increased after leptin
treatment as compared to control ob/ob (P=0.015 and P=
0.023, respectively) and pair-fed ob/ob (P=0.036 and P=0.034,
respectively) mice.
Leptin reduces the immunocomplexes of TBC1D1 and
TBC1D4 with GLUT4 in ob/ob mice
Since TBC1D1 and TBC1D4 proteins bind GLUT4 to block its
translocation from intracellular storage compartments to the
plasma membrane, we resolved GLUT4 from the immunopre-
cipitated samples of TBC1D1 and TBC1D4 in gastrocnemius
muscle to examine whether GLUT4 co-precipitates with TBC1D1
and TBC1D4 proteins. As shown in Figure 4B and E-, GLUT4
signals detected in immunoprecipitated samples from TBC1D1
tended to be reduced by leptin treatment as compared to control
ob/ob and pair-fed ob/ob mice, although statistically significant
differences were not reached. A similar pattern was observed for
GLUT4 in immunoprecipitated samples from TBC1D4, which
was reduced in leptin-treated ob/ob as compared to control ob/ob
Figure 1. Effect of leptin on glucose transporter GLUT4 expression in skeletal muscle. A: Real-Time PCR analysis of Glut4 mRNA in the
gastrocnemius, extensor digitorum longus (EDL) and soleus muscles of wild type, control ob/ob, pair-fed ob/ob and leptin-treated ob/ob mice (n=6
per group). B: Representative Western blot analysis of GLUT4 of the gastrocnemius, EDL and soleus muscles of wild type, control ob/ob, pair-fed ob/ob
and leptin-treated ob/ob mice. b-actin was used as a loading control (n=6 per group). Values are presented as means6SEM. * P,0.05 by one-way
ANOVA followed by LSD tests.
doi:10.1371/journal.pone.0029389.g001
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No statistical differences were detected between control ob/ob and
pair-fed ob/ob groups for GLUT4 proteins in immunoprecipitated
samples from TBC1D1 and TBC1D4.
Discussion
The purpose of our study was to examine the in vivo effects of
leptin replacement on key molecules regulating GLUT4 translo-
cation in skeletal muscle of the obese and diabetic ob/ob mice. Our
findings show, for the first time, that leptin administration
represses the increased transcript levels and activity of the negative
regulators of GLUT4 traffic Tbc1d1 and Tbc1d4 in the gastroc-
nemius muscle of ob/ob mice.
Food intake restriction modulates insulin sensitivity and the
expression of GLUT4 in human and rodent insulin sensitive
tissues [23,24]. Our data confirm that leptin significantly improves
insulin sensitivity in ob/ob mice independently of the reduction in
food intake. However, the effect of leptin on basal or insulin-
stimulated glucose uptake in skeletal muscle has yielded many
paradoxical observations [25]. No effect of leptin on glucose
uptake was observed in human skeletal muscle cells [26], isolated
mouse soleus [27] or rat epitrochlearis muscles [28]. In contrast,
several in vitro studies have reported that leptin increases basal
Figure 2. Effect of leptin on the intracellular location of GLUT4 protein in skeletal muscle. Representative images of GLUT4
immunostaining in sections of the gastrocnemius, extensor digitorum longus (EDL) and soleus of wild type (WT), control ob/ob (OB), pair-fed ob/ob
(PF) and leptin-treated ob/ob (LE) mice. Larger-magnification images within black frames of immunohistochemical staining for GLUT4 in
gastrocnemius, EDL and soleus sections of leptin-treated ob/ob mice are shown. Arrows indicate punctuate distribution of GLUT4 vesicles in plasma
membrane and cytosol of muscle sections. Scale bars=50 mm.
doi:10.1371/journal.pone.0029389.g002
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mice [29]. Furthermore, in vivo leptin treatment increases the
glucose uptake in skeletal muscle [17] and improves the insulin
sensitivity in normal [30] and diabetic rodents [15] as well as in
leptin-deficient ob/ob mice [31].
Translocation of GLUT4 from intracellular depots to the
plasma membrane of cells is key in glucose uptake, but GLUT4
traffic disruption in human type 2 diabetes has been described [2].
Several studies have examined the role of leptin on GLUT4
translocation showing controversial results. Acute treatment with
leptin reduced insulin-stimulated glucose uptake without altering
insulin-stimulated GLUT4 translocation in muscle cells of rats
[32]. Furthermore, in the absence of insulin, high concentrations
of leptin are unable to induce GLUT4 translocation in the soleus
of rats [33]. Contrarily, leptin caused a small increase in glucose
uptake and movement of GLUT4 to the plasma membrane in
C2C12 muscle cells [16,34]. In addition, chronic leptin treatment
normalized basal glucose transport and GLUT4 content in soleus,
but not in the gastrocnemius of high-fat-fed rats [35], as well as the
insulin-stimulated GLUT4 content at the cell surface of myotubes
without any reduction in total GLUT4 expression [36]. In the
present study, GLUT4 mRNA expression was reduced by leptin
deficiency in the EDL of control ob/ob mice, but it was not
modified by leptin administration. In addition, no differences were
detected for gene and protein expression levels of GLUT4
between wild type and ob/ob groups in gastrocnemius and soleus
in spite of the normalization of serum glucose and insulin
sensitivity induced by leptin replacement in leptin-treated ob/ob
animals. A plausible explanation for this finding may relate to the
leptin enhancement of GLUT4 activity by inhibiting the activity of
TBC1D1 and TBC1D4 and via the alteration of the GLUT4
protein intracellular localization. In this sense, the activity of both
TBC1D1 and TBC1D4 can be inhibited by phosphorylation by
Akt and AMPK on PAS motif sites in response to insulin or
contractile activity [37,38,39]. Impaired insulin-induced GLUT4
traffic and phosphorylation of TBC1D4 [40] are restored by
endurance exercise-training in skeletal muscle of type 2 diabetes
patients [41]. In addition, insulin-stimulated glucose transport and
cell surface GLUT4 content are reduced in isolated muscles of
mice with Tbc1d4-Thr649Ala knockin mutation, but not in
adipocytes [42], while inhibition of Tbc1d4 in 3T3-L1 adipocytes
increases the content of GLUT4 in the plasma membrane [43]. In
contrast, knockdown of Tbc1d1 in 3T3-L1 adipocytes does not
alter the insulin-stimulated GLUT4 translocation to the plasma
membrane, whereas its overexpression partially inhibits the
translocation of GLUT4 induced by AMPK [44]. A substantial
body of evidence links the activation of AMPK with the reduction
of the rate of GLUT4 endocytosis in skeletal muscle [45]. While
Akt increases glucose uptake mainly through its action on
TBC1D4, AMPK mediates it via the inhibition of TBC1D1 in
skeletal muscle of rats [46]. More recently it has been reported that
the catalytic AMPK-a2 is the main subunit of AMPK regulating
TBC1D1-Ser237 phosphorylation in mice skeletal muscle [47],
while disruption of AMPK-a1 signaling prevents the suppressive
effects of AMPK activation on TBC1D4 phosphorylation [48]. In
this sense, leptin activates AMPK in skeletal muscle [20,21] and
direct or indirect activation of AMPK stimulates the gene
expression of GLUT4 [18,49] and promotes its translocation to
Figure 3. Effect of leptin on the expression in skeletal muscle of the negative regulators of GLUT4 translocation, TBC1D1 and
TBC1D4. Real-Time PCR analysis of Tbc1d1 (A) and Tbc1d4 (B) mRNA in the gastrocnemius, extensor digitorum longus (EDL) and soleus muscles of
wild type, control ob/ob, pair-fed ob/ob and leptin-treated ob/ob mice (n=6 per group). Values are presented as means6SEM. * P,0.05, ** P,0.01
and *** P,0.001 by one-way ANOVA followed by LSD tests.
doi:10.1371/journal.pone.0029389.g003
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e29389Figure 4. Effect of leptin on the regulation of the negative regulators of GLUT4 translocation, TBC1D1 and TBC1D4. A: Representative
phospho-Akt substrate (PAS) immunoblot of gastrocnemius lysate of wild type (WT), control ob/ob (OB), pair-fed ob/ob (PF) and leptin-treated ob/ob
(LE) mice. The arrow indicates the band that may correspond to TBC1D1/4. B: Representative blots of immunoprecipitation and immunoblotting
experiments. Equal amounts of protein (250 mg) from lysates of the gastrocnemius of WT, OB, PF and LE mice were incubated with TBC1D1 or
TBC1D4 antibodies. Immunoprecipitated (IP) samples of TBC1D1 and TBC1D4 were resolved by SDS-PAGE and membranes were immunoblotted
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PCR data evidenced that administration of leptin suppresses the
increased gene expression levels of Tbc1d1 and Tbc1d4 in ob/ob
mice. In addition, leptin replacement enhanced the lower PAS-
TBC1D1 and PAS-TBC1D4 protein levels in ob/ob mice, at the
same time as reducing protein complexes of GLUT4 with
TBC1D4. Therefore, given that the phosphorylation of TBC1D1
and TBC1D4 suppresses its GAP activity allowing for the
translocation of GLUT4 vesicles to the plasma membrane, our
findings indicate that leptin may inhibit the activity of TBC1D1
and TBC1D4 in the gastrocnemius of ob/ob mice. Noteworthy, a
decrease of the expression of Tbc1d1 and Tbc1d4 in gastrocnemius
muscle of pair fed ob/ob, thought to a lesser extent than in leptin-
treated ob/ob, was determined. In this respect, given that weight
loss has beneficial effects on skeletal muscle insulin sensitivity
[23,24], the possibility that weight loss may alter the TBC1D1 and
TBC1D4 expression and/or phosphorylation in skeletal muscle
independently of a direct leptin effect should be considered.
However, PAS-TBC1D1 and PAS-TBC1D4 levels were increased
after leptin administration in leptin-treated ob/ob as compared to
control ob/ob and pair-fed ob/ob groups. In addition, several in vitro
and in vivo studies have reported that expression and phosphor-
ylation of TBC1D1 and TBC1D4 in skeletal muscle of rodents
[24] and humans [50,51] are not affected by diet intervention and
weight loss. Furthermore, in a previous study, leptin administra-
tion did not modify body weight and total TBC1D4 protein
expression in soleus of rats, but the hormone was able to recover
the in vitro impaired insulin-stimulated phosphorylation of
TBC1D4 induced by high-fat diet [52]. These studies suggest
that modulations of the phosphorylation of TBC1D1 and
TBC1D4 do not appear to be early components of the adaptation
to weight loss. In this context, discerning whether the improved
insulin sensitivity after leptin treatment is associated with an
increased insulin-stimulated phosphorylation of TBC1D1 and/or
TBC1D4 represents an important topic for future investigations.
In skeletal muscle, TG accumulation leads to insulin resistance.
Circulating concentrations of FFA modulate the insulin sensitivity
and GLUT4 expression in skeletal muscle with high intramyocel-
lular content leading to insulin resistance [53]. In this sense, serum
FFA were not modified by leptin deficiency or administration. In
addition, although higher circulating concentrations of FFA and
TG were detected in pair-fed ob/ob as compared to leptin-treated
ob/ob mice, no differences for intramyocellular TG content were
found. Data suggests an additional effect of leptin on the
modulation of the expression and phosphorylation of TBC1D1
and TBC1D4 in ob/ob mice independently of the reduction of food
intake and circulating concentrations of FFA and TG content in
muscle cells.
Consistent with our results, GLUT4 gene and protein
expression were not altered in skeletal muscle of insulin-resistant
subjects [54] and in skeletal muscle of rats with increased insulin
sensitivity after exercise [55,56], or chronic leptin treatment
[17,57]. Regulation of glucose uptake has been shown to be fiber-
type specific in skeletal muscle of rodents [58,59]. In addition, a
muscle-specific fiber-type expression of GLUT proteins has been
reported in several studies [60,61,62]. To date, 14 members of the
GLUT family have been identified, but 3 of them (GLUT4,
GLUT5 and GLUT12) account for 98% of the mRNA in human
skeletal muscle [62]. Stuart et al. [62] showed that GLUT3,
GLUT4 and GLUT12 are predominantly expressed in slow-
twitch oxidative fibers of human skeletal muscle. In contrast, the
GLUT5 isoform was predominantly detected in fast-twitch
glycolytic fibers. Moreover, GLUT12 has been recently identified
as a potential candidate for a second insulin-responsive glucose
transporter in muscle and fat [63] and a positive regulation of
GLUT5 activity and expression by oral administration of leptin
has been reported in jejunum of rodents [64]. In the present study,
leptin treatment increased transcript levels of GLUT3 and
GLUT12 in ob/ob animals. These data suggests that GLUT3
and GLUT12 may be key targets for leptin in skeletal muscle of
ob/ob mice, thereby warranting further studies in this direction.
Paradoxically, leptin increased GLUT4 immunostaining in fiber
sections of the glycolytic muscle EDL of leptin-treated ob/ob mice,
without altering the total GLUT4 protein content by immuno-
blotting. In addittion, the hormone was unable to modify the
GLUT4 staining pattern in the oxidative muscle soleus consistent
with immunoblotting results. Controversial results about GLUT4
protein expression by different methods have been detected in
several studies [65,66,67]. GLUT4 is expressed in different cell
types in skeletal muscle tissue. In addition, both fiber-type-
dependent and independent factors affect GLUT-4 expression
[65,68] and although EDL is a glycolytic muscle it is composed by
different fiber types. Thus, the results on the expression of GLUT4
by immunoblotting and immunostaining in our study would
probably be more in accordance performing immunoblotting
experiments on single muscle fibers to avoid the influence of
another cell type and discriminate the effect of the different fiber
types. Furthermore, in the mixed muscle gastrocnemius, total
GLUT4 protein content was not different between wild type and
ob/ob groups, but the GLUT4 immunostaining pattern induced by
leptin administration was almost exclusively relegated to some
fibers, as compared to leptin-deficient mice (control ob/ob and
pair-fed ob/ob groups), in which the staining pattern of GLUT4
was uniformly distributed among all the gastrocnemius fibers.
Leptin appears to increase the GLUT4 signal preferably in some
fibers rather than in all of them. Therefore, given that leptin
administration was unable to modify the GLUT4 protein
abundance in muscle but increased the GLUT4 signal in EDL
sections, the lack of differences in GLUT4 protein abundance
between groups may be explained by an increase in GLUT4
expression in glycolytic fibers masked by a decrease in the
oxidative ones. Another possibility is that leptin alters the
intracellular localization of GLUT4 in a fiber-type dependent
manner in the gastrocnemius. Accordingly, we can not rule out the
possibility that the lack of a leptin effect on GLUT4 mRNA and
protein levels may be related to a fiber-type specific effect of the
hormone, while warrants future studies for its elucidation.
Subsequently to GLUT4 translocation, a required point for
glucose uptake is the fusion of GLUT4-containing vesicles to the
plasma membrane. This process is mediated by SNARE proteins
[8,9]. In this sense, the present study shows, for the first time, that
leptin administration up-regulates gene expression of proteins
involved in the fusion of GLUT4-containing vesicles with the
plasma membrane, such as Vamp2, Stx4 and Stxbp4 in the
(WB) using PAS and GLUT4 antibodies. Membranes of immunoprecipitates probed with PAS and GLUT4 antibodies were stripped and re-probed with
the corresponding total antibody TBC1D1 and TBC1D4. The signals from PAS-TBC1D1 and GLUT4-TBC1D1 and PAS-TBC1D4 and GLUT4-TBC1D4 were
related to total TBC1D1 and TBC1D4, respectively (n=6 per group). Leptin increases the phosphorylation levels of TBC1D1 (C) and TBC1D4 (D) in the
gastrocnemius of leptin-treated ob/ob mice. GLUT4 co-precipitates with intracellular TBC1D1 (E) and TBC1D4 (F) proteins. Values are presented as
means6SEM. * P,0.05 by one-way ANOVA followed by LSD tests.
doi:10.1371/journal.pone.0029389.g004
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the transcript levels of Sort1, which plays an essential role in the
formation of GLUT4 storage vesicles in adipocytes [69] and
muscle cells [70]. In addition, overexpression of sortilin in C2C12
cells enhances the insulin-induced glucose transport by increasing
the gene expression levels of GLUT4 [70]. In accordance with our
study, a recent report has further shown that mRNA levels of
sortilin are down-regulated in adipose tissue and muscles of ob/ob
and db/db mice as well as morbidly obese humans [71].
In summary, our findings provide new insights into the
molecular mechanisms triggered by leptin in the regulation of
glucose metabolism. Data suggests that leptin replacement
improves the defective glucose homeostasis of ob/ob mice
enhancing the presence of GLUT4 in the plasma membrane of
the skeletal muscle cells by reducing the expression and increasing
the phosphorylation of the negative regulators of GLUT4
translocation TBC1D1 and TBC1D4.
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